Overview
I am the founder of a biotech startup dedicated to revolutionizing cancer treatment through innovative therapies. Our focus is on developing a proprietary treatment that utilizes a unique combination of biologics and advanced delivery methods. This approach not only aims to minimize the side effects commonly associated with traditional therapies but also significantly increases the potency against various cancer types. Currently, we have successfully completed initial preclinical trials showing promising efficacy and safety profiles. We are seeking an investor who understands the healthcare market and recognizes the potential impact of our treatment solutions. The requested investment will be pivotal in scaling our operations and moving towards human clinical trials within the next year. Looking for an investor who understands the market and can support practical growth. We are raising capital to advance our groundbreaking therapeutic methodologies that target cancer cells more effectively, enhancing patient outcomes significantly. Development of targeted cancer therapies that improve efficacy and reduce side effects.
Use of funds
The $1,200,000 investment will be allocated as follows: 60% for clinical trial preparations and execution, 20% for regulatory compliance and documentation, 15% for market research to optimize our go-to-market strategy, and 5% for operational costs including staffing and facility enhancements.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.